AXSOME THERAPEUTICS, INC. (AXSM) Operating income 2016–2025
AXSOME THERAPEUTICS, INC. (AXSM) annual operating income history from SEC filings — each fiscal year as reported.
-$166.8MFY2025 · since FY2016: -$27.5M → -$166.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$166.8M | +40.6% |
| FY2024 | -$280.6M | -21.0% |
| FY2023 | -$231.8M | -28.9% |
| FY2022 | -$179.8M | -44.2% |
| FY2021 | -$124.7M | -25.8% |
| FY2020 | -$99.1M | -47.4% |
| FY2019 | -$67.2M | -104.7% |
| FY2018 | -$32.8M | -20.9% |
| FY2017 | -$27.2M | +1.4% |
| FY2016 | -$27.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AXSM financial trends
AXSM RevenueAXSM Net incomeAXSM Net marginAXSM Gross profitAXSM Gross marginAXSM Operating marginAXSM Operating cash flowAXSM Free cash flowAXSM Capital expendituresAXSM Return on equityAXSM Stock buybacksAXSM Dividends paidAXSM Total assetsAXSM Total liabilitiesAXSM Shareholders’ equityAXSM overview →